Korean Drug Co Stock Cash Per Share

014570 Stock  KRW 4,270  90.00  2.06%   
Korean Drug Co fundamentals help investors to digest information that contributes to Korean Drug's financial success or failures. It also enables traders to predict the movement of Korean Stock. The fundamental analysis module provides a way to measure Korean Drug's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Korean Drug stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Korean Drug Co Company Cash Per Share Analysis

Korean Drug's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Cash Per Share

 = 

Total Cash

Average Shares

More About Cash Per Share | All Equity Analysis

Current Korean Drug Cash Per Share

    
  980.50 X  
Most of Korean Drug's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Korean Drug Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Competition

In accordance with the recently published financial statements, Korean Drug Co has a Cash Per Share of 980 times. This is much higher than that of the Healthcare sector and significantly higher than that of the Pharmaceuticals industry. The cash per share for all Republic of Korea stocks is notably lower than that of the firm.

Did you try this?

Run Volatility Analysis Now

   

Volatility Analysis

Get historical volatility and risk analysis based on latest market data
All  Next Launch Module

Korean Fundamentals

About Korean Drug Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Korean Drug Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Korean Drug using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Korean Drug Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Korean Drug

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Korean Drug position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Korean Drug will appreciate offsetting losses from the drop in the long position's value.

Moving together with Korean Stock

  0.89074430 Aminologics CoLtdPairCorr

Moving against Korean Stock

  0.56032830 Samsung LifePairCorr
  0.5316140 Woori Financial GroupPairCorr
  0.46105560 KB Financial GroupPairCorr
  0.43216080 JETEMAPairCorr
  0.42065660 AnterogenCoLtdPairCorr
The ability to find closely correlated positions to Korean Drug could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Korean Drug when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Korean Drug - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Korean Drug Co to buy it.
The correlation of Korean Drug is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Korean Drug moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Korean Drug moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Korean Drug can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Korean Stock

Korean Drug financial ratios help investors to determine whether Korean Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Korean with respect to the benefits of owning Korean Drug security.